First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
http://link.springer.com/article/10.1007/s12032-017-1076-1/fulltext.html
Reference18 articles.
1. Zibellini S, Capello D, Forconi F, et al. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica. 2010;95:1792–6. http://www.ncbi.nlm.nih.gov/pubmed/20511668.
2. Boveri E, Arcaini L, Merli M, et al. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Ann Oncol Off J Eur Soc Med Oncol. 2009;20:129–36. http://www.ncbi.nlm.nih.gov/pubmed/18718888.
3. Spina V, Rossi D. Molecular pathogenesis of splenic and nodal marginal zone lymphoma. Best Pract Res Clin Haematol. 30:5–12. http://www.ncbi.nlm.nih.gov/pubmed/28288716.
4. Castelli R, Wu MA, Arquati M, et al. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency. Br J Haematol. 2016;172:902–8. http://www.ncbi.nlm.nih.gov/pubmed/26728240.
5. Arcaini L, Rossi D, Lucioni M, et al. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection. Haematologica. 2015;100:246–52. http://www.ncbi.nlm.nih.gov/pubmed/25381127.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Spleen-targeted delivery systems and strategies for spleen-related diseases;Journal of Controlled Release;2024-06
2. Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2024-06
3. Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline;British Journal of Haematology;2023-11-13
4. Splenisches Marginalzonenlymphom;Indolente Lymphome;2023
5. Risk-tailored treatment of splenic marginal zone lymphoma;Anti-Cancer Drugs;2021-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3